Safa, Houssein <br/><br/>
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.  [electronic resource] 

 -  Journal for immunotherapy of cancer  11 2019 
 - 319 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Review; Systematic Review 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-019-0774-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Biomarkers<br/>Disease Progression<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--adverse effects<br/>Myasthenia Gravis--diagnosis<br/>Neoplasms--complications<br/>Symptom Assessment